Magscon 50_ Magnesium Sulphate Injection

Get a Price/Quote

MOQ : 10 Packs

Magscon 50_ Magnesium Sulphate Injection Specification

Life Span
36 months from manufacture

Packaging Type
Ampoules packed in box

Pacakaging (Quantity Per Box)
10 ampoules per box

Brand Name
Magscon 50

Indication
Eclampsia, pre-eclampsia, magnesium supplementation

Salt Composition
Magnesium Sulphate 50% w/v

Dosage Form
Injection

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Magnesium Sulphate

Physical Form
Liquid/Injection

Function
Treats magnesium deficiency, prevents eclamptic seizures

Recommended For
Pre-eclampsia, eclampsia, magnesium deficiency, seizures associated with pregnancy

Dosage
As directed by the physician

Dosage Guidelines
Administer intravenously or intramuscularly as advised

Quantity
Available in 2 ml and 10 ml ampoules

Storage Instructions
Store in a cool, dry place, away from sunlight

Country of Export
Available internationally (including Canada, Europe, UK, USA, Australia)

Administration
IV/IM use only

Usage/Application
Hospital, clinical, emergency medical care

Strength
500 mg/ml (50% solution)

Prescription Required
Yes

Regulatory Status
Complies with standard pharmacopeia guidelines

Appearance
Clear, colorless solution

Side Effects
May include flushing, sweating, lowered blood pressure (refer to leaflet)

Magscon 50_ Magnesium Sulphate Injection Trade Information

Minimum Order Quantity
10 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Magscon 50_ Magnesium Sulphate Injection About

Get swift, reliable intervention with Magscon 50_ Magnesium Sulphate Injection-a top-rated, laureate formulation trusted by venerable medical professionals worldwide. Delivering a sterling 500 mg/ml (50%) solution, Magscon 50 is expertly designed for hospital, clinical, and emergency medical care. Administered via IV or IM, this prescription-only injectable addresses conditions like pre-eclampsia, eclampsia, magnesium deficiency, and pregnancy-related seizures. Available in clear, colorless ampoules of 2 ml or 10 ml, each pack ensures international-standard compliance. Secure instant checkout and experience prompt, global shipping for hospital-grade assurance.

Targeted Care for Critical Conditions

Magscon 50_ Magnesium Sulphate Injection is specifically recommended for emergency medical care, treating severe magnesium deficiency, pre-eclampsia, and eclampsia, with potent efficacy in preventing pregnancy-related seizures. Administered intravenously or intramuscularly under clinical supervision, Magscon 50 ensures precise dosage and optimized therapeutic outcomes. Site of application is strictly hospital and specialized clinical settings, making it ideal for acute care professionals seeking proven solutions in high-stakes environments.

Timely Delivery and Verified Quality

With a strong domestic market presence and stellar export logistics, Magscon 50 assures rapid order completion and delivery across Canada, Europe, the UK, USA, and Australia. Each batch is certified to standard pharmacopeia guidelines and is available in sample quantities. Competitive sale prices and secure packaging further streamline the ordering process, so healthcare facilities can maintain stock efficiently, confident in the product's certified quality and timely arrival.

FAQ's of Magscon 50_ Magnesium Sulphate Injection:

Q: How is Magscon 50_ Magnesium Sulphate Injection typically administered?

A: Magscon 50 is administered intravenously (IV) or intramuscularly (IM) by healthcare professionals in hospital or clinical settings, following a physician's prescribed dosage.

Q: What are the main uses of Magscon 50_ Magnesium Sulphate Injection?

A: Magscon 50 is primarily used for managing pre-eclampsia, eclampsia, severe magnesium deficiency, and preventing seizures associated with pregnancy.

Q: When should Magscon 50_ Magnesium Sulphate Injection be used?

A: It should be prescribed and administered during conditions like pre-eclampsia, eclampsia, or clinically diagnosed magnesium deficiency, as directed by a healthcare provider.

Q: Where can Magscon 50_ Magnesium Sulphate Injection be exported or purchased?

A: Magscon 50 is available for international export, including regions such as Canada, Europe, the UK, USA, and Australia, through authorized medical suppliers.

Q: What does the certification process involve for Magscon 50?

A: Each batch of Magscon 50 complies with reputed pharmacopeia guidelines, ensuring high quality and safety; detailed certifications are available upon request.

Q: What are the key benefits of using Magscon 50 for patients?

A: The main benefit is fast, effective management of critical magnesium deficiency and prevention of life-threatening seizures in high-risk pregnancy cases, under clinical supervision.

Tell us about your requirement